Shares of Sage Therapeutics up on Zulresso approval, but analysts expect a slow rollout
March 20, 2019 at 09:49 AM EDT
Shares of Sage Therapeutics Inc. rose 3% Wednesday morning after the company’s announcement Tuesday evening that the Food and Drug Administration had approved its drug for the treatment of postpartum depression.
